Octagon Capital Advisors LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001839435

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q1 2024 · 56 positions · Total reported value $669.38M · Top-10 concentration 47.7% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 65.5% · 2 new · 14 cut · 3 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -23.3% · vs SPY -25.4% · Prev Value $1.11B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -9.9% · vs SPY -12.0% · Latest Value $750.61M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q1 2024 13F filing, Octagon Capital Advisors LP disclosed 56 equity positions with a combined reported value of $669.38M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 47.7% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2024 were ALPN ($49.21M), DNTH ($41.42M), VRNA ($38.12M). By sector, the heaviest allocations are Health Care 64.3%, Industrials 3.4%. Versus the prior quarter, allocation shifted toward Health Care (+20.8pp), Industrials (+3.4pp) and away from Other (-24.2pp).

Versus the prior quarter, Octagon Capital Advisors LP opened 2 new positions, trimmed 14 and fully exited 3, a turnover rate of 65.5% of positions. The portfolio's overlap with the prior quarter was 37% of names.

The largest new positions opened in Q1 2024 were AVBP ($34.72M), EYPT ($22.60M), OCUL ($22.07M).

Of the 3 positions fully exited versus the prior quarter, the largest were CBAY ($63.15M), RCUS ($35.68M), CLDX ($28.06M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2024)

  • AVBP ARRIVENT BIOPHARMA INC · $34.72M
  • EYPT EYEPOINT INC · $22.60M
  • OCUL OCULAR THERAPEUTIX INC · $22.07M
  • MNMD MIND MEDICINE MINDMED INC · $20.24M
  • CATX PERSPECTIVE THERAPEUTICS INC · $17.51M
  • CRBP CORBUS PHARMACEUTICALS HLDGS · $15.89M
  • PRAX PRAXIS PRECISION MEDICINES I · $15.87M
  • TNYA TENAYA THERAPEUTICS INC · $14.93M

Fully Exited (vs previous quarter)

  • CBAY CYMABAY THERAPEUTICS INC · prev qtr: $63.15M
  • RCUS ARCUS BIOSCIENCES INC · prev qtr: $35.68M
  • CLDX CELLDEX THERAPEUTICS INC NEW · prev qtr: $28.06M
  • ROIV ROIVANT SCIENCES LTD · prev qtr: $28.01M
  • GRCL GRACELL BIOTECHNOLOGIES INC · prev qtr: $5.99M
  • INZY INOZYME PHARMA INC · prev qtr: $1.70M
  • XLO XILIO THERAPEUTICS INC · prev qtr: $981.75K
  • MIRM MIRUM PHARMACEUTICALS INC · prev qtr: $738.00K · history

Insider Transactions (Form 4)

Latest Octagon Capital Advisors LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Octagon Capital Advisors LP is an SEC-registered 13F filer based in New York, NY, United States. As of Q3 2026 it reported 26 US equity positions with a combined value of $750.61M. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-118554 (status: Approved), registered 2020-04-27
  • Regulatory AUM (Form ADV): $1.18B as of 2026-03-20
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 4 private funds, of which 1 hedge funds
  • Website: octagoninvestments.com

Portfolio Structure

  • 26 positions · $750.61M reported value (Q3 2026)
  • Top 10 holdings = 82.5% of reported value
  • Largest position: DNTH (DIANTHUS THERAPEUTICS INC) at 19.8%
  • Average position size: $28.87M

Sector Tilt

  • Health Care 99.6%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q3 2026: 2 new, 1 added, 14 reduced, 3 exited
  • 9 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 64.3%
Other 32.3%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 1.24M $49.21M 7.35%
7.35%
Hold
2 1.38M $41.42M 6.19%
6.19%
Add
3 2.37M $38.12M 5.69%
5.69%
Hold
4 1.24M $35.29M 5.27%
5.27%
Add
5 1.94M $34.72M 5.19%
5.19%
New
6 1.14M $30.93M 4.62%
4.62%
Reduce
7 2.06M $23.28M 3.48%
3.48%
Hold
8 1.09M $22.60M 3.38%
3.38%
New
9 2.42M $22.07M 3.30%
3.30%
New
10 506.60K $21.71M 3.24%
3.24%
Add
11 690.00K $21.33M 3.19%
3.19%
Reduce
12 2.15M $20.24M 3.02%
3.02%
New
13 14.72M $17.51M 2.62%
2.62%
New
14 405.00K $15.89M 2.37%
2.37%
New
15 260.00K $15.87M 2.37%
2.37%
New
16 2.85M $14.93M 2.23%
2.23%
New
17 500.81K $14.70M 2.20%
2.20%
Reduce
18 2.05M $14.70M 2.20%
2.20%
Hold
19 194.00K $13.60M 2.03%
2.03%
Add
20 403.69K $11.94M 1.78%
1.78%
Hold
21 200.00K $11.76M 1.76%
1.76%
Reduce
22 620.00K $10.86M 1.62%
1.62%
Hold
23 9.19M $10.84M 1.62%
1.62%
Hold
24 408.00K $9.65M 1.44%
1.44%
New
25 3.00M $9.00M 1.34%
1.34%
Hold
26 273.29K $8.83M 1.32%
1.32%
Hold
27 3.03M $8.70M 1.30%
1.30%
New
28 340.00K $8.59M 1.28%
1.28%
New
29 1.50M $8.26M 1.23%
1.23%
New
30 18.60M $7.69M 1.15%
1.15%
New
31 250.00K $7.15M 1.07%
1.07%
New
32 550.00K $7.10M 1.06%
1.06%
New
33 315.00K $6.80M 1.02%
1.02%
New
34 376.12K $5.53M 0.83%
0.83%
New
35 1.00M $5.06M 0.76%
0.76%
New
36 1.37M $5.00M 0.75%
0.75%
Add
37 455.00K $4.83M 0.72%
0.72%
Add
38 1.00M $4.48M 0.67%
0.67%
New
39 625.00K $4.10M 0.61%
0.61%
New
40 520.80K $3.82M 0.57%
0.57%
New
41 2.25M $3.73M 0.56%
0.56%
Hold
42 165.00K $3.72M 0.56%
0.56%
Add
43 360.80K $3.61M 0.54%
0.54%
New
44 1.10M $3.58M 0.54%
0.54%
Add
45 720.00K $3.22M 0.48%
0.48%
New
46 4.20M $3.17M 0.47%
0.47%
New
47 3.80M $2.66M 0.40%
0.40%
Hold
48 292.00K $2.62M 0.39%
0.39%
Hold
49 240.00K $2.59M 0.39%
0.39%
New
50 250.00K $2.59M 0.39%
0.39%
New

FAQ

What did Octagon Capital Advisors LP buy in 2024-Q1?

In its 2024-Q1 13F filing, Octagon Capital Advisors LP reported 56 equity positions worth $669.38M in aggregate; its largest disclosed positions were ALPN ($49.21M), DNTH ($41.42M), VRNA ($38.12M).

How large is Octagon Capital Advisors LP's portfolio?

Octagon Capital Advisors LP reported $669.38M of long equity holdings across 56 positions as of 2024-Q1. Top-10 holdings account for 47.7% of reported value.

What is Octagon Capital Advisors LP's investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/octagon-capital-advisors/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →